Document is current
Any future updates will be listed below
-
Authors
Schmidt-Hieber, Martin https://orcid.org/0000-0002-3071-6945
Velasco, Roser https://orcid.org/0000-0003-3194-9406
Penack, Olaf https://orcid.org/0000-0003-4876-802X
Averbuch, Dina https://orcid.org/0000-0001-9614-7274
Balaguer-Roselló, Aitana https://orcid.org/0000-0003-1633-2918
Baccelli, Francesco https://orcid.org/0000-0003-2242-3998
Bataller, Luis https://orcid.org/0000-0002-2471-4492
Cesaro, Simone https://orcid.org/0000-0002-8698-9547
Briani, Chiara https://orcid.org/0000-0001-8035-0200
de la Cámara, Rafael https://orcid.org/0000-0002-8189-5779
Huehnchen, Petra https://orcid.org/0000-0002-6825-7270
de Silva, Thushan https://orcid.org/0000-0002-6498-9212
Mussetti, Alberto https://orcid.org/0000-0002-4088-036X
Ljungman, Per https://orcid.org/0000-0002-8281-3245
Perić, Zinaida https://orcid.org/0000-0001-9458-8025
Mikulska, Malgorzata https://orcid.org/0000-0002-5535-4602
Polushin, Alexey https://orcid.org/0000-0001-8699-2482
Navarro, David https://orcid.org/0000-0003-3010-4110
Pons-Escoda, Albert https://orcid.org/0000-0003-4167-8291
Neofytos, Dionysios https://orcid.org/0000-0001-6970-2869
Schoemans, Hélène https://orcid.org/0000-0002-7568-8239
Piñana, José Luis https://orcid.org/0000-0001-8533-2562
Onida, Francesco https://orcid.org/0000-0002-2991-3474
Ruggeri, Annalisa https://orcid.org/0000-0002-7261-2765
Sanchez-Ortega, Isabel https://orcid.org/0009-0005-5519-9154
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Styczynski, Jan https://orcid.org/0000-0002-3158-119X
- License Information
-
More Information
Article History
Received: 6 March 2026
Revised: 22 March 2026
Accepted: 14 April 2026
First Online: 13 May 2026
Competing interests
: DA: Speaker Takeda, MSD. DN: Conference fees: bioMérieux, Abbott Diagnostics. HS: Received personal fees from Incyte, Novartis, MAAT Pharma, Mallinckrodt Pharmaceuticals, Sanofi, BeiGene and the Belgian Haematological Society (BHS), as well as research funding from Sanofi, all paid to her institution and not directly related to this work. She has also received non-financial support from Pfizer, Sanofi, AbbVie, the EBMT, the IACH (International Academy for Clinical Haematology) and the CIBMTR (Center for International Bone Marrow Transplantation Research). JS: Participated in advisory boards for AstraZeneca, Moderna, MSD; and has been a speaker for Gilead, MSD, Roche and AstraZeneca. The other authors declare no competing financial interests related to this work.
